[27-58-pm1] Science for Drug Formulation 5, Testing, property and stability of medicinal formulation, Novel formulations/Others

[27-58-pm1-07] Evaluation of Stability and Safety of Brain-Penetrant KS-133 Formulation for the Development of Schizophrenia Therapy

○Kotaro Sakamoto¹, Runa Fujimoto¹, Zihao Jin², Daichi Koan³, Kazuto Nunomura², Shinsaku Nakagawa², Yukio Ago³ (1. Ichimaru Pharcos Co. Ltd., 2. The University of Osaka, 3. Hiroshima University)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.